These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 29588427)
1. Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture. Hachemi Y; Rapp AE; Picke AK; Weidinger G; Ignatius A; Tuckermann J J Mol Endocrinol; 2018 Jul; 61(1):R75-R90. PubMed ID: 29588427 [TBL] [Abstract][Full Text] [Related]
2. Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases. Lee S; Krüger BT; Ignatius A; Tuckermann J Front Endocrinol (Lausanne); 2021; 12():815386. PubMed ID: 35082759 [TBL] [Abstract][Full Text] [Related]
3. Treatment with synthetic glucocorticoid impairs bone metabolism, as revealed by in vivo imaging of osteoblasts and osteoclasts in medaka fish. Azetsu Y; Chatani M; Dodo Y; Karakawa A; Sakai N; Negishi-Koga T; Takami M Biomed Pharmacother; 2019 Oct; 118():109101. PubMed ID: 31315073 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor signaling in bone cells. Moutsatsou P; Kassi E; Papavassiliou AG Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718 [TBL] [Abstract][Full Text] [Related]
6. Induced global deletion of glucocorticoid receptor impairs fracture healing. Rapp AE; Hachemi Y; Kemmler J; Koenen M; Tuckermann J; Ignatius A FASEB J; 2018 Apr; 32(4):2235-2245. PubMed ID: 29217668 [TBL] [Abstract][Full Text] [Related]
7. A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology. Ahmad M; Hachemi Y; Paxian K; Mengele F; Koenen M; Tuckermann J Front Immunol; 2019; 10():2460. PubMed ID: 31681333 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123 [TBL] [Abstract][Full Text] [Related]
9. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489 [TBL] [Abstract][Full Text] [Related]
10. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation. Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Chen M; Fu W; Xu H; Liu CJ Cytokine Growth Factor Rev; 2023 Apr; 70():54-66. PubMed ID: 36906448 [TBL] [Abstract][Full Text] [Related]
12. Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone development. Tu J; Henneicke H; Zhang Y; Stoner S; Cheng TL; Schindeler A; Chen D; Tuckermann J; Cooper MS; Seibel MJ; Zhou H Bone; 2014 Dec; 69():12-22. PubMed ID: 25193158 [TBL] [Abstract][Full Text] [Related]
13. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Olkku A; Mahonen A Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor signaling in the eye. Sulaiman RS; Kadmiel M; Cidlowski JA Steroids; 2018 May; 133():60-66. PubMed ID: 29129720 [TBL] [Abstract][Full Text] [Related]
15. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology. Sevilla LM; Pérez P Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221 [TBL] [Abstract][Full Text] [Related]
16. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Vandevyver S; Dejager L; Tuckermann J; Libert C Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs). Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049 [TBL] [Abstract][Full Text] [Related]
18. Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues. Sharma AK; Shi X; Isales CM; McGee-Lawrence ME Curr Osteoporos Rep; 2019 Dec; 17(6):438-445. PubMed ID: 31749087 [TBL] [Abstract][Full Text] [Related]
19. Non-genomic effect of glucocorticoids on cardiovascular system. Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways. Jiang Y; Lu Y; Jiang X; Hu J; Li R; Liu Y; Zhu G; Rong X Biomed Pharmacother; 2020 May; 125():109979. PubMed ID: 32044718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]